COMP <GO>
PRGO vs MRK // NET PROFIT MARGIN
Perrigo Company plc (NYSE) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: PRGO 3
— MRK 8
▲ NET PROFIT MARGIN LEADER: MRK
LAST: $15.78 (-0.75%) • MKT CAP: $2.21B
net-margins
-33.50%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
net-margins
28.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PRGO VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PRGO | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 35.10% | 74.80% | -39.70 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -13.60% | 20.70% | -34.30 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 6.58% | 3.42% | +3.16 | PRGO | /fcf-yield <GO> |
| Operating Margin | -26.40% | 34.30% | -60.70 | MRK | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -33.50% | 28.10% | -61.60 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | -2.80% | 1.30% | -4.10 | MRK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 7.22% | 2.26% | +4.96 | PRGO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 5.19 | -4.99 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.7 | 51.7 | +5.00 | PRGO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.21B | $361.02B | -$358.81B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PRGO REV | MRK REV | PRGO GROSS % | MRK GROSS % | PRGO FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.25B | $65.01B | 35.1% | 74.8% | $145.1M | $12.36B |
| FY 2024 | $4.37B | $64.17B | 35.3% | 76.3% | $244.6M | $18.10B |
| FY 2023 | $4.66B | $60.12B | — | — | $405.5M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PRGO // BETA —
MRK // BETA 0.92